Caroline Clairmont
- Molecular Biology
- Biotechnology top 1%
- Biomedical Engineering top 10%
- Genetics top 10%
- Oncology top 10%
- Co-authors
- Mario SznolC B HirschbergJoann B. SweasyAntonio De MaioAnn CahillJoseph A. KuhnRobert CavagnoloNeil Senzer
- Topics
- Cancer Research and Treatments (5 papers)DNA Repair Mechanisms (5 papers)Glycosylation and Glycoproteins Research (2 papers)
- Cited by
- BiotechnologyGeneticsOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesSwedenPoland
In The Last Decade
Caroline Clairmont
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 598
- Biotechnology 514
- Biomedical Engineering 358
- Genetics 333
- Oncology 276
Countries citing papers authored by Caroline Clairmont
This map shows the geographic impact of Caroline Clairmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Clairmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Clairmont more than expected).
Fields of papers citing papers by Caroline Clairmont
This network shows the impact of papers produced by Caroline Clairmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Clairmont. The network helps show where Caroline Clairmont may publish in the future.
Co-authorship network of co-authors of Caroline Clairmont
This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Clairmont. A scholar is included among the top collaborators of Caroline Clairmont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Clairmont. Caroline Clairmont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Combination of KS119W with other antitumor agents for the treatment of murine and human tumor xenografts in mice | 1 |
| 2 | 15 | |
| 3 | 78 | |
| 4 | 37 | |
| 5 | 119 | |
| 6 | 261 | |
| 7 | Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors. | 97 |
| 8 | 283 | |
| 9 | 3 | |
| 10 | 20 | |
| 11 | 36 | |
| 12 | 13 | |
| 13 | 47 | |
| 14 | 83 | |
| 15 | 26 | |
| 16 | 7 | |
| 17 | 38 | |
| 18 | 119 | |
| 19 | 9 |
About Caroline Clairmont
Caroline Clairmont is a scholar working on Biotechnology, Hematology and Cancer Research, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Research and Treatments (5 papers), DNA Repair Mechanisms (5 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Biotechnology (514 citations), Genetics (333 citations) and Oncology (276 citations). Caroline Clairmont has collaborated with scholars based in United States, Sweden and Poland. Frequent co-authors include Mario Sznol, C B Hirschberg, Joann B. Sweasy, Antonio De Maio, Ann Cahill, Joseph A. Kuhn, Robert Cavagnolo, Neil Senzer, Casey Cunningham and John Nemunaitis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.